Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole added to lithium or valproate for long-term maintenance treatment of bipolar I mania
2005-001233-16Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Apr 2006
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of aripiprazole, lithium carbonate and divalproex sodium in bipolar I disorder (4 arms), sponsored by Bristol Myers Squibb. Primary endpoint: Time from randomization to relapse to any mood episode. Started Apr 2006; status: completed.
02
Drugs
aripiprazolelithium carbonatedivalproex sodium
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on 2005-001233-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001233-16.